Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Mar;48(3):223-5.
doi: 10.1136/jcp.48.3.223.

Iron metabolism and fungal infections in patients with haematological malignancies

Affiliations

Iron metabolism and fungal infections in patients with haematological malignancies

C Iglesias-Osma et al. J Clin Pathol. 1995 Mar.

Abstract

Aim: To determine whether iron metabolism influences the incidence of systemic fungal infection in patients with haematological malignancies.

Methods: The study population comprised 74 patients who had undergone myeloablative chemotherapy. Systemic fungal infections were classified as confirmed (histological confirmation or characteristic septate hyphae) or possible (antibiotic resistant fever which resolved following administration of intravenous amphotericin B, together with either typical radiographic lesions or massive oropharyngeal candidiasis). Parameters of iron metabolism included serum iron concentrations, total iron binding capacity, serum transferrin, and ferritin concentrations and transferrin saturation values.

Results: Patients who developed a fungal infection had substantially increased transferrin saturation values and ferritin concentrations at diagnosis together with low serum transferrin and high serum iron concentrations. This profile was present in patients with a fungal infection regardless of the underlying haematological disorder.

Conclusion: Increased transferrin saturation values and high ferritin concentrations may be additional risk factors for the development of systemic fungal infection in patients with haematological malignancies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Infect Immun. 1983 Jun;40(3):1134-9 - PubMed
    1. Cancer. 1983 Jan 1;51(1):61-4 - PubMed
    1. Am J Clin Pathol. 1984 Jun;81(6):748-53 - PubMed
    1. Biochem Biophys Res Commun. 1985 Jul 31;130(2):885-91 - PubMed
    1. J Clin Oncol. 1986 Feb;4(2):216-20 - PubMed